RADX
RADIOPHARM SP ADR (RADX)
NASDAQ
$1.44-$0.04 (-3.04%)
Price as of Oct 02, 2026 5:12 PM EDT
  • $21.6M
    Market Cap
  • -75.58%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2026
06/30/2025
Income Statement
Total Operating Revenue
2.8M
-23.82%
3.6M
N/A
Cost of Revenue
2.5M
-30.32%
3.6M
N/A
Gross Profit
263,389
+570.61%
39,276
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
-27.5M
N/A
Depreciation and Amortization Expense
2.7M
+4.25%
2.6M
N/A
Total Operating Expenses
16.2M
+10.78%
14.6M
N/A
Operating Profit
-56.8M
+48.75%
-38.2M
N/A
Interest Income
637,144
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
637,144
N/A
0
N/A
Total Nonoperating Income and Expense
10.7M
+4.66%
10.3M
N/A
Income before Taxes
N/A
N/A
-38.3M
N/A
Income Taxes
N/A
N/A
103,292
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-38.3M
N/A
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-38.3M
N/A
Basic EPS and Net Income
-1.79
+1.70%
-1.76
N/A
Diluted EPS and Net Income
-1.79
+1.70%
-1.76
N/A
Basic Weighted Average Shares
3.1B
+47.68%
2.1B
N/A
Diluted Weighted Average Shares
3.1B
+47.68%
2.1B
N/A
Balance Sheet
Cash and Cash Equivalents
4.1M
-85.79%
29.1M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
4.1M
-85.79%
29.1M
N/A
Total Current Assets
4.1M
-89.62%
39.9M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
46,136
-13.71%
53,466
N/A
Total Long-Term Assets
38.2M
-18.06%
46.6M
N/A
Total Assets
60.1M
-30.47%
86.5M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
N/A
N/A
14.9M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
18.9M
-34.05%
28.7M
N/A
Total Liabilities
37.8M
-13.30%
43.6M
N/A
Retained Earnings
-174.4M
+12.71%
-154.7M
N/A
Total Stockholders Equity
N/A
N/A
42.9M
N/A
Total Shares Outstanding
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-52.8M
+44.04%
-36.6M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
-5.4M
-406.16%
1.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
33.4M
-26.54%
45.4M
N/A
Financials Ratio
Gross Margin
9.52%
N/A
N/A
N/A
Operating Margin
-2,051.52%
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
Revenue Growth
-23.82%
N/A
N/A
N/A
Current Ratio
N/A
N/A
N/A
N/A
Cash Ratio
N/A
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow